Premier Alternatives

Calibrate

New York, NY · Founded 2019 · Privately Held (backing)

Developer of a weight management platform designed to improve metabolic health to drive long-term and sustainable weight loss. Calibrate is based in New York, NY and was founded in 2019. Its last reported valuation was $389 million in Oct 2023. It has raised $170 million.

Last reported valuation
$388.6M
Oct 2026
Priced at
—
Total raised
$170.1M
Last round
—

Calibrate key facts

as of Oct 2026
  • Developer of a weight management platform designed to improve metabolic health to drive long-term and sustainable weight loss.
  • Calibrate is valued at approximately $388.6M as of Oct 2026 (last reported valuation).
  • It has raised $170.1M; the latest was PE Growth/Expansion in May 2025.
  • Notable investors include Mana Ventures, Gaingels, Founders Fund, Forerunner Ventures, What If Ventures — 11 tracked in total.
  • 1 investment vehicle was formed to buy Calibrate shares in the last 12 months, reporting $5.1M sold to 2 investors, per SEC Form D filings.
  • Status: Privately Held (backing).
Last reported valuation
LOW confidence
$388.6M

Calibrate's last reported valuation, Oct 2023. Nothing priced has surfaced since.

set by last reported valuationas of Oct 2026question about this number?
Free account
More of Calibrate with a free account
  • ·The complete investor list: 11 names
  • ·Watch Calibrate: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Calibrate funding rounds

No rounds on record

No funding rounds for Calibrate are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.

Pro members can request priority coverage with a 48-hour turnaround.

Vehicles formed to buy Calibrate shares

secondary demand · SEC Form D filings

In the last 12 months, 1 investment vehicle were formed to buy Calibrate shares, reporting $5.1M sold to 2 investors. Most recent filing May 2026.

The vehicle list — each sponsor, filing date, amount sold and investor count — is a Pro table. Unlock the 1 vehicle →

Membership and data by Private Market View

Companies with the most vehicle activity →

Calibrate valuation

Calibrate's last reported valuation was $389 million in Oct 2023. No priced round, secondary trade or fund mark has surfaced since.

Institutional holders and vehicles

In the last 12 months, 1 investment vehicle was formed to buy Calibrate shares, reporting $5.1 million sold to 2 investors, per SEC Form D filings (most recent May 2026).

Calibrate investors

11 investors are on record for Calibrate, including Mana Ventures, Gaingels, Founders Fund and Forerunner Ventures. By type, the record holds 7 venture capital firms.

About Calibrate

Developer of a weight management platform designed to improve metabolic health to drive long-term and sustainable weight loss. The company's platform offers telemedicine metabolic medications with purpose-built behavior change to catalyze the physiological changes for vital sustained metabolic health care medication outcomes-based model in obesity treatment and offers value-based pricing to control GLP-1(glucagon-like peptide-1), one-on-one video doctor visits, and personal coaching, enabling patients to lose their body weight and stay fit and healthy.

Sector
Healthcare
HQ
New York, NY, United States
Founded
2019
Employees
366
Ownership
Privately Held (backing)

Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.